20000 Participants Needed

Assessments for Cancer Risk

Recruiting at 6 trial locations
VB
KA
Overseen ByKyra Anderson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Colorado, Denver
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve cancer care by studying samples, such as blood and tissue, from individuals with cancer or those at risk. Researchers will collect and analyze these samples and related data to advance medicine. The focus is not on testing new treatments but on gathering information to enhance future care. The trial seeks participants diagnosed with cancer or those who believe they might be at risk. As an unphased trial, this study offers participants the chance to contribute to valuable research that could shape the future of cancer care.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. Since this is not a treatment study, it's likely you can continue your medications, but you should confirm with the study team.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on gathering comprehensive data from patients who have or may be at risk for cancer. Unlike standard treatments that directly target cancer cells, this approach emphasizes the collection of blood, tissue, and other biological samples, along with detailed medical and survey data. This holistic dataset is crucial because it can lead to breakthroughs in understanding cancer, potentially paving the way for personalized medicine and more effective, tailored treatments in the future. By combining biospecimen collection with extensive data analysis, this trial aims to unlock new insights into cancer prevention and management.

Who Is on the Research Team?

VB

Virginia Borges, MD

Principal Investigator

University of Colorado, Denver

Are You a Good Fit for This Trial?

Inclusion Criteria

Diagnosed with cancer, or may be at risk for cancer.
Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through a legally authorized representative (LAR).
Non-English speaking subjects will also be invited to participate in the TCCP study, in accordance with COMIRB's short-form consent use.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

Biospecimen and Data Collection

Collection of blood, tissue, and other biological samples along with associated data from patients with cancer or at risk of having cancer

Up to 20 years

Follow-up

Participants are monitored for safety and effectiveness after data collection

Up to 20 years

What Are the Treatments Tested in This Trial?

Interventions

  • Biospeciman Collection
  • Medical Chart Reviews
  • Survey Assessments

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Biospeciman and Data CollectionExperimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials
1,842
Recruited
3,028,000+